CAPR

30.12

0.92% -0.28

Dopo l'orario di chiusura: 30.19 0.07 +0.23%

Capricor Therapeutics Inc (CAPR)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché CAPR Giù? Forum Previsione Frazionamento azionario

Precedente Chiudi:

$30.40

Aprire:

$30.45

Volume 24 ore:

1.86M

Relative Volume:

1.38

Capitalizzazione di mercato:

$1.73B

Reddito:

$11.13M

Utile/perdita netta:

$-105.04M

Rapporto P/E:

-13.35

EPS:

-2.2565

Flusso di cassa netto:

$-81.54M

1 W Prestazione:

+0.74%

1M Prestazione:

+7.84%

6M Prestazione:

+285.17%

1 anno Prestazione:

+217.89%

Intervallo 1D:

$29.95

$31.74

Intervallo di 1 settimana:

$27.50

$31.74

Portata 52W:

$4.30

$40.37

Capricor Therapeutics Inc Stock (CAPR) Company Profile

Nome

Capricor Therapeutics Inc

Settore

Healthcare (1116)

Industria

Biotechnology (621)

Telefono

(310) 358-3200

Indirizzo

10865 ROAD TO THE CURE, SAN DIEGO, CA

Dipendente

231

Cinguettio

@Capricor

Prossima data di guadagno

2026-03-12

Ultimi documenti SEC

CAPR's Discussions on Twitter

Compare CAPR vs VRTX, REGN, ARGX, ALNY, INSM

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
CAPR Capricor Therapeutics Inc	30.12	1.75B	11.13M	-105.04M	-81.54M	-2.2565
VRTX Vertex Pharmaceuticals Inc	447.26	113.44B	12.07B	3.95B	3.19B	15.33
REGN Regeneron Pharmaceuticals Inc	777.25	81.68B	14.34B	4.50B	3.77B	41.56
ARGX Argen X Se Adr	743.12	45.32B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	328.73	43.88B	3.71B	313.75M	465.38M	2.2571
INSM Insmed Inc	164.86	35.25B	606.42M	-1.28B	-997.58M	-6.403

Capricor Therapeutics Inc Stock (CAPR) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-06-30	Iniziato	Alliance Global Partners	Buy
2025-06-26	Iniziato	B. Riley Securities	Buy
2025-05-20	Iniziato	Roth Capital	Buy
2024-10-21	Iniziato	Piper Sandler	Overweight
2024-05-17	Iniziato	Oppenheimer	Outperform
2024-01-05	Iniziato	Cantor Fitzgerald	Overweight
2022-10-26	Iniziato	Ladenburg Thalmann	Buy
2018-12-26	Downgrade	Maxim Group	Buy → Hold
2018-01-26	Reiterato	H.C. Wainwright	Buy
2017-09-15	Reiterato	H.C. Wainwright	Buy
2017-02-13	Ripresa	Rodman & Renshaw	Buy
2016-07-06	Ripresa	H.C. Wainwright	Buy
2016-06-15	Iniziato	ROTH Capital	Buy

Mostra tutto

Capricor Therapeutics Inc Borsa (CAPR) Ultime notizie

08:13 AM

Capricor (NASDAQ: CAPR) CFO sells 25K shares after option exercise - stocktitan.net

08:13 AM

Director at Capricor (NASDAQ: CAPR) sells 115,000 shares via 10b5-1 plan - stocktitan.net

08:13 AM

08:04 AM

Capricor Therapeutics director sells $3.5m in shares - investing.com

08:04 AM

Mar 31, 2026

Capricor Therapeutics (NASDAQ: CAPR) proxy: Board nominees, pay and Nippon Shinyaku deals - stocktitan.net

Mar 31, 2026

[144] CAPRICOR THERAPEUTICS, INC. SEC Filing - stocktitan.net

Mar 31, 2026

Mar 30, 2026

Insider Sell: Is Capricor Therapeutics Inc stock a good dividend stock2026 Price Momentum & Safe Capital Preservation Plans - baoquankhu1.vn

Mar 30, 2026

Value Recap: Is Capricor Therapeutics Inc a defensive stock2026 Levels & Weekly High Potential Stock Alerts - baoquankhu1.vn

Mar 30, 2026

Is Capricor Therapeutics Inc stock a good dividend stock2026 Retail Activity & Daily Chart Pattern Signal Reports - baoquankhu1.vn

Mar 30, 2026

Mar 29, 2026

Capricor Therapeutics (CAPR) reports positive phase 3 HOPE-3 data and $318M 2025 cash balance - MSN

Mar 29, 2026

Mar 27, 2026

Capricor (CAPR) EVP and General Counsel exercises options for 2,500 shares - stocktitan.net

Mar 27, 2026

Bull Run: Does Capricor Therapeutics Inc stock benefit from AI growth2026 Support & Resistance & Real-Time Sentiment Analysis - baoquankhu1.vn

Mar 27, 2026

CAPR Technical Analysis | Trend, Signals & Chart Patterns | CAPRICOR THERAPEUTICS INC (NASDAQ:CAPR) - ChartMill

Mar 27, 2026

Mar 25, 2026

Momentum Shift: Is AKAM a top pick in the sectorTreasury Yields & Comprehensive Market Scan Reports - baoquankhu1.vn

Mar 25, 2026

Merger Talk: How does Capricor Therapeutics Inc perform in inflationary periods2026 Opening Moves & Safe Entry Trade Reports - baoquankhu1.vn

Mar 25, 2026

Capricor Therapeutics Opens with 10.29% Gain, Outperforming S&P 500's 0.83% Rise - Markets Mojo

Mar 25, 2026

Mar 24, 2026

Technical Reactions to CAPR Trends in Macro Strategies - Stock Traders Daily

Mar 24, 2026

Mar 23, 2026

Capricor Therapeutics Tokenized Stock (Ondo) price today, CAPRon to USD live price, marketcap and chart - CoinMarketCap

Mar 23, 2026

Mar 22, 2026

Capricor Therapeutics, Inc.(NasdaqGS:CAPR) added to S&P Biotechnology Select Industry Index - marketscreener.com

Mar 22, 2026

Q4 2025 Capricor Therapeutics Inc Earnings Call Transcript - GuruFocus

Mar 22, 2026

Mar 21, 2026

Capricor Therapeutics, Inc. (NASDAQ:CAPR) Receives Average Rating of "Moderate Buy" from Analysts - marketbeat.com

Mar 21, 2026

Mar 20, 2026

Capricor Therapeutics (CAPR) price target increased by 32.98% to 51.82 - MSN

Mar 20, 2026

Mar 19, 2026

Why Capricor Therapeutics (CAPR) Is Down 8.0% After FDA Resumes Deramiocel Review And Phase 3 Update - Sahm

Mar 19, 2026

Mar 18, 2026

Growth Review: Is Capricor Therapeutics Inc a defensive stock2026 EndofYear Setup & Long-Term Safe Return Strategies - baoquankhu1.vn

Mar 18, 2026

Capricor Therapeutics Pipeline Overview: Deramiocel for Muscular Dystrophy and Exosome-Based Vaccine Development (2025-2026) - Minichart

Mar 18, 2026

Decoding Capricor Therapeutics Inc (CAPR): A Strategic SWOT Insight - GuruFocus

Mar 18, 2026

Capricor Therapeutics to Present Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Update on March 12 - 富途牛牛

Mar 18, 2026

Decoding Capricor Therapeutics Inc (CAPR): A Strategic SWOT Insi - GuruFocus

Mar 18, 2026

CAPR SEC FilingsCapricor Therapeutics Inc 10-K, 10-Q, 8-K Forms - Stock Titan

Mar 18, 2026

Mar 17, 2026

Capricor Therapeutics (CAPR) Reports Positive Phase 3 HOPE-3 Data and $318M 2025 Cash Balance - Insider Monkey

Mar 17, 2026

Capricor Therapeutics 2025 10-K: Revenue $0, EPS $(2.26) - TradingView

Mar 17, 2026

Deramiocel DMD program and big Nippon Shinyaku deals at Capricor (NASDAQ: CAPR) - Stock Titan

Mar 17, 2026

About Capricor Therapeutics (Ondo Tokenized) - Coinbase

Mar 17, 2026

13 Best Hot Stocks to Buy According to Analysts - Insider Monkey

Mar 17, 2026

Capricor Therapeutics, Inc. (NASDAQ:CAPR) Q4 2025 Earnings Call Transcript - Insider Monkey

Mar 17, 2026

Mar 16, 2026

CAPR Stock Slumps But Wall Street Reiterates Optimism For Deramiocel Approval - Stocktwits

Mar 16, 2026

A Look At Capricor Therapeutics’ (CAPR) Valuation After FDA Resumes Deramiocel Review On New HOPE-3 Data - Sahm

Mar 16, 2026

Q1 Earnings Forecast for CAPR Issued By HC Wainwright - MarketBeat

Mar 16, 2026

Mar 15, 2026

Capricor Therapeutics Hits Day High with 8.06% Surge in Stock Price - Markets Mojo

Mar 15, 2026

Mar 14, 2026

Is It Too Late To Reassess Capricor Therapeutics (CAPR) After Its Recent 130% Surge? - Yahoo Finance

Mar 14, 2026

Capricor Therapeutics (CAPR) Posts US$50 Million H1 Loss Reinforcing Bearish Cash Burn Narrative - simplywall.st

Mar 14, 2026

Mar 13, 2026

CAPR Stock: Analyst B. Riley Securities Raises Price Target to $ - GuruFocus

Mar 13, 2026

Capricor Therapeutics Nears Key Milestones After Earnings Call - TipRanks

Mar 13, 2026

Deramiocel Poised to Be First Therapy for DMD's Cardiac and Skeletal Issues - Intellectia AI

Mar 13, 2026